购物车
全部删除
您的购物车当前为空
Memantine 是口服具有活性的、非竞争性的N-甲基-D-天冬氨酸受体拮抗剂,可用于研究中重度阿尔茨海默病。

Memantine 是口服具有活性的、非竞争性的N-甲基-D-天冬氨酸受体拮抗剂,可用于研究中重度阿尔茨海默病。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 142 | 现货 | |
| 5 mg | ¥ 287 | 现货 | |
| 10 mg | ¥ 407 | 现货 | |
| 25 mg | ¥ 665 | 现货 | |
| 50 mg | ¥ 981 | 现货 | |
| 100 mg | ¥ 1,460 | 现货 | |
| 500 mg | ¥ 3,550 | 现货 |
Memantine 相关产品
| 产品描述 | Memantine, an amantadine derivative with some dopaminergic effects, has been proposed as an antiparkinson agent and has may be used to treat moderate to severe Alzheimer's disease. It acts on the glutamatergic system by blocking NMDA receptors. |
| 分子量 | 179.3 |
| 分子式 | C12H21N |
| CAS No. | 19982-08-2 |
| Smiles | CC12CC3CC(C)(C1)CC(N)(C3)C2 |
| 密度 | 1.046 |
| 存储 | Pure form: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 250 mg/mL (1394.31 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 1 mg/mL (5.58 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容